Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review

被引：141
作者：
Ariza-Heredia, Ella J. [1 ]
Nesher, Lior [1 ]
Chemaly, Roy F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
来源：
CANCER LETTERS | 2014年 / 342卷 / 01期
关键词：
Cytomegalovirus; Stem cell transplantation; Viral infections; BONE-MARROW-TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; NERVOUS-SYSTEM DISEASE; PREEMPTIVE THERAPY; DOUBLE-BLIND; VIRAL LOAD; T-CELLS; HEMATOLOGICAL MALIGNANCIES; RESISTANT CYTOMEGALOVIRUS; MARIBAVIR PROPHYLAXIS;
D O I：
10.1016/j.canlet.2013.09.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cytomegalovirus (CMV) infection remains a significant complication after hematopoietic stem cell transplantation (HSCT) and may have a deleterious impact on the overall outcome after transplantation. In addition to the direct effects of CMV infection, tissue-invasive CMV diseases may be associated with increased risk of graft versus host disease, myelosuppression, and invasive bacterial and fungal infections. Because of these direct and indirect adverse effects, prevention of CMV infection, mostly through pre-emptive therapy, is one of the essential strategies that may improve outcomes of HSCT recipients. Management of CMV infection relies mainly on intravenous (IV) antiviral therapy with ganciclovir and foscarnet, with or without IV polyclonal immunoglobulins. Although viral resistance remains rare, better tolerated antiviral agents with less serious side effects are needed, and a few will be evaluated in phase III clinical trials in the near future. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：1 / 8
页数：8
相关论文
共 72 条
[1]   Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients [J].
Alexander, Bryan T. ;
Hladnik, Lindsay M. ;
Augustin, Kristan M. ;
Casabar, Ed ;
McKinnon, Peggy S. ;
Reichley, Richard M. ;
Ritchie, David J. ;
Westervelt, Peter ;
Dubberke, Erik R. .
PHARMACOTHERAPY, 2010, 30 (06) :554-561
[2]   Cytomegalovirus ventriculoencephalitis in a reduced- intensity conditioning cord blood transplant recipient [J].
Ando, T. ;
Mitani, N. ;
Yamashita, K. ;
Takahashi, T. ;
Ohama, E. ;
Miyata, H. ;
Yujiri, T. ;
Tanizawa, Y. .
TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (05) :441-445
[3]   Performance of the QuantiFERON-Cytomegalovirus (CMV) Assay for Detection and Estimation of the Magnitude and Functionality of the CMV-Specific Gamma Interferon-Producing CD8+ T-Cell Response in Allogeneic Stem Cell Transplant Recipients [J].
Angeles Clari, Maria ;
Munoz-Cobo, Beatriz ;
Solano, Carlos ;
Benet, Isabel ;
Costa, Elisa ;
Jose Remigia, Maria ;
Bravo, Dayana ;
Amat, Paula ;
Navarro, David .
CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (05) :791-796
[4]   Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants [J].
Aubert, G ;
Hassan-Walker, AF ;
Madrigal, JA ;
Emery, VC ;
Morte, C ;
Grace, S ;
Koh, MBC ;
Potter, M ;
Prentice, HG ;
Dodi, IA ;
Travers, PJ .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (08) :955-963
[5]   Update in management of ganciclovir-resistant cytomegalovirus infection [J].
Avery, Robin K. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (04) :433-437
[6]   Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes [J].
Avery, Robin K. ;
Mossad, Sherif B. ;
Poggio, Emilio ;
Lard, Michelle ;
Budev, Marie ;
Bolwell, Brian ;
Waldman, W. James ;
Braun, William ;
Mawhorter, Steven D. ;
Fatica, Richard ;
Krishnamurthi, Venkatesh ;
Young, James B. ;
Shrestha, Rabin ;
Stephany, Brian ;
Lurain, Nell ;
Yen-Lieberman, Belinda .
TRANSPLANTATION, 2010, 90 (04) :419-426
[7]   Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation [J].
Battiwalla, M. ;
Paplham, P. ;
Almyroudis, N. G. ;
McCarthy, A. ;
Abdelhalim, A. ;
Elefante, A. ;
Smith, P. ;
Becker, J. ;
McCarthy, P. L. ;
Segal, B. H. .
TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (01) :28-32
[8]   Impact of Cytomegalovirus (CMV) Reactivation after Umbilical Cord Blood Transplantation [J].
Beck, Jill C. ;
Wagner, John E. ;
DeFor, Todd E. ;
Brunstein, Claudio G. ;
Schleiss, Mark R. ;
Young, Jo-Anne ;
Weisdorf, Daniel H. ;
Cooley, Sarah ;
Miller, Jeffrey S. ;
Verneris, Michael R. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) :215-222
[9]   Antiviral drugs for cytomegalovirus diseases [J].
Biron, Karen K. .
ANTIVIRAL RESEARCH, 2006, 71 (2-3) :154-163
[10]   The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy [J].
Boeckh, M ;
Nichols, WG .
BLOOD, 2004, 103 (06) :2003-2008
12345678